{"id":"https://openalex.org/W145668544","doi":null,"title":"Solubility and dissolution improvement of Rofecoxib using solid dispersion technique.","display_name":"Solubility and dissolution improvement of Rofecoxib using solid dispersion technique.","alternate_titles":[],"publication_year":2008,"publication_date":"2008-10-01","ids":{"openalex":"https://openalex.org/W145668544","mag":"145668544","pmid":"https://pubmed.ncbi.nlm.nih.gov/18930854"},"language":"en","primary_location":{"id":"pmid:18930854","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18930854","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pakistan journal of pharmaceutical sciences","raw_type":"Comparative Study"},"parent_works":[],"lineage":["https://openalex.org/W145668544"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091048061","display_name":"Mohamed Rahamathulla","orcid":"https://orcid.org/0000-0001-8826-3718","observed_orcids":["https://orcid.org/0000-0001-8826-3718"]},"institutions":[{"id":"https://openalex.org/I149840157","display_name":"Al-Arab Medical University","ror":"https://ror.org/03ke9vf24","country_code":"LY","type":"education","lineage":["https://openalex.org/I149840157"]}],"countries":["LY"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mohamed Rahamathulla","raw_affiliation_strings":["Al Arab Medical Sciences University, Dept. of Pharmaceutics, Faculty of pharmacy, Benghazi 5341, Libya. rahmathmsu@yahoo.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Al Arab Medical Sciences University, Dept. of Pharmaceutics, Faculty of pharmacy, Benghazi 5341, Libya. rahmathmsu@yahoo.com","institution_ids":["https://openalex.org/I149840157"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002534601","display_name":"Hosahalli Veerabhadrappa Gangadharappa","orcid":"https://orcid.org/0000-0002-2961-4108","observed_orcids":["https://orcid.org/0000-0002-2961-4108"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gangadharappa Hv","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5067315089","display_name":"Neelkant Rathod","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Neelkant Rathod","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.6566,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.78061655,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":95},"biblio":{"volume":"21","issue":"4","first_page":"350","last_page":"355"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rofecoxib","display_name":"rofecoxib","score":1.0},{"id":"https://openalex.org/keywords/solid-dispersion","display_name":"solid dispersion","score":0.9509999752044678},{"id":"https://openalex.org/keywords/solubility-enhancement","display_name":"solubility enhancement","score":0.7919999957084656},{"id":"https://openalex.org/keywords/dissolution-enhancement","display_name":"dissolution enhancement","score":0.8460000157356262},{"id":"https://openalex.org/keywords/cox-2-inhibitors","display_name":"COX-2 inhibitors","score":0.8009999990463257},{"id":"https://openalex.org/keywords/polyethylene-glycol","display_name":"polyethylene glycol","score":0.828000009059906},{"id":"https://openalex.org/keywords/polyvinylpyrrolidone","display_name":"polyvinylpyrrolidone","score":0.9879999756813049},{"id":"https://openalex.org/keywords/drug-polymer-interactions","display_name":"drug-polymer interactions","score":0.8820000290870667},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.41499999165534973}],"concepts":[{"id":"https://openalex.org/C155574463","wikidata":"https://www.wikidata.org/wiki/Q170731","display_name":"Solubility","level":2,"score":0.865861177444458},{"id":"https://openalex.org/C88380143","wikidata":"https://www.wikidata.org/wiki/Q416674","display_name":"Dissolution","level":2,"score":0.8646798133850098},{"id":"https://openalex.org/C2778582115","wikidata":"https://www.wikidata.org/wiki/Q411412","display_name":"Rofecoxib","level":4,"score":0.8261394500732422},{"id":"https://openalex.org/C54400483","wikidata":"https://www.wikidata.org/wiki/Q1793202","display_name":"PEG ratio","level":2,"score":0.6670159101486206},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6123436093330383},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.4875178039073944},{"id":"https://openalex.org/C2780471494","wikidata":"https://www.wikidata.org/wiki/Q146505","display_name":"Solvent","level":2,"score":0.47718656063079834},{"id":"https://openalex.org/C2781430271","wikidata":"https://www.wikidata.org/wiki/Q278760","display_name":"Biopharmaceutics Classification System","level":3,"score":0.46736428141593933},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.4607677459716797},{"id":"https://openalex.org/C13965031","wikidata":"https://www.wikidata.org/wiki/Q243545","display_name":"Nuclear chemistry","level":1,"score":0.45512980222702026},{"id":"https://openalex.org/C14029885","wikidata":"https://www.wikidata.org/wiki/Q5282807","display_name":"Dissolution testing","level":4,"score":0.45370644330978394},{"id":"https://openalex.org/C177562468","wikidata":"https://www.wikidata.org/wiki/Q182893","display_name":"Dispersion (optics)","level":2,"score":0.41109147667884827},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32063889503479004},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.17305782437324524},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.14548525214195251},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C2779689624","wikidata":"https://www.wikidata.org/wiki/Q410251","display_name":"Cyclooxygenase","level":3,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004337","descriptor_name":"Drug Carriers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007783","descriptor_name":"Lactones","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011205","descriptor_name":"Povidone","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013450","descriptor_name":"Sulfones","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D013678","descriptor_name":"Technology, Pharmaceutical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:18930854","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18930854","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pakistan journal of pharmaceutical sciences","raw_type":"Comparative Study"},{"id":"mag:145668544","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18930854","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W1995990957","https://openalex.org/W1998213501","https://openalex.org/W2013871444","https://openalex.org/W2014390215","https://openalex.org/W2015025440","https://openalex.org/W2045794651","https://openalex.org/W2047654053","https://openalex.org/W2114515973","https://openalex.org/W2158661590","https://openalex.org/W2464070975","https://openalex.org/W2471183959","https://openalex.org/W2471722929","https://openalex.org/W2473733679","https://openalex.org/W2527599034"],"related_works":["https://openalex.org/W7095234702","https://openalex.org/W2091114916","https://openalex.org/W2170726185","https://openalex.org/W2109056932","https://openalex.org/W55940663","https://openalex.org/W2141569620","https://openalex.org/W3160657221","https://openalex.org/W2112616379","https://openalex.org/W2060871208"],"abstract_inverted_index":{"Rofecoxib":[0],"(RXB)":[1],"is":[2,41],"a":[3,125],"potent":[4],"and":[5,26,70,94,109,168,207],"selective":[6],"cyclo-oxygenase-2":[7],"(COX-2)":[8],"inhibitor,":[9],"highly":[10],"effective":[11],"in":[12,110,115,163],"the":[13,37,203],"treatment":[14],"of":[15,55,72,101,127,145,173,182,205,209],"various":[16,79,106,183],"pains,":[17],"inflammatory":[18],"condition,":[19],"post-operative":[20],"pain,":[21],"rheumatoid":[22],"arthritis,":[23],"other":[24],"musculo-skeletal":[25],"joint":[27],"disorders.":[28],"Although":[29],"they":[30],"are":[31],"completely":[32],"absorbed":[33],"upon":[34],"oral":[35,46],"administration,":[36],"peak":[38],"plasma":[39],"concentration":[40],"reached":[42],"2-3":[43],"hours":[44],"after":[45,170],"ingestion.":[47],"The":[48,98,143,155],"reason":[49],"for":[50,124,202],"delay":[51],"being":[52],"slow":[53],"rate":[54],"absorption":[56],"due":[57],"to":[58,67,105,160,198],"poor":[59],"aqueous":[60],"solubility.":[61],"An":[62],"attempt":[63],"has":[64],"been":[65],"made":[66],"enhance":[68,161],"solubility":[69,208],"dissolution":[71,113,138,157,174,206],"rofecoxib":[73],"by":[74,91,193],"solid":[75],"dispersion(SD)":[76],"technique":[77],"using":[78,130,141],"hydrophilic":[80],"excipients":[81],"like":[82],"PEG":[83,85,164,166],"4000,":[84,165],"6000,":[86],"PVP":[87,189],"at":[88,186,190],"different":[89],"ratios":[90],"melting":[92],"method":[93,195],"solvent":[95],"evaporation":[96],"method.":[97],"prepared":[99],"SD":[100],"RXB":[102],"were":[103],"characterized":[104],"physico-chemical":[107],"properties":[108],"vitro":[111],"drug":[112,156],"studies":[114],"0.1N":[116],"HCl":[117],"with":[118],"0.25%":[119],"SLS":[120],"(pH":[121],"1.1)":[122],"media":[123],"period":[126],"90":[128,171],"min":[129],"USP":[131],"XXIII":[132],"electro":[133],"lab":[134],"8":[135],"basket":[136],"tab":[137],"test":[139],"apparatus":[140],"paddle.":[142],"result":[144],"study":[146,175],"indicated":[147],"that":[148],"there":[149],"was":[150,158,196],"no":[151],"drug-polymer":[152],"interaction":[153],"found.":[154],"found":[159,197],"percent":[162],"6000":[167],"PVP,":[169],"mins":[172],"79.02%,":[176],"88.02%,":[177],"98.57%":[178],"respectively.":[179],"On":[180],"comparison":[181],"polymers":[184],"used":[185],"varied":[187],"concentrations":[188],"75:25":[191],"ratio":[192],"fusion":[194],"be":[199],"best":[200],"suitable":[201],"enhancement":[204],"RXB.":[210]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W145668544","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
